Determination of glutathione S-transferase μ and θ polymorphisms in neurological disease

Human and Experimental Toxicology

Volumn 18, Issue 3, 1999, Pages 141-145

  Stroombergen, Maudy C M J ^a,b   Waring, Rosemary H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Allele specific PCR; Alzheimer's disease; Glutathione S transferase; GSTM1; GSTT1; Motor neuron disease; Parkinson's disease

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; NEUROLOGIC DISEASE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX RATIO;

EID: 0032974480     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719901800302     Document Type: Article

References (40)

1. Haradam S, Abei M. Human glutathione S-transferase. In: Pharmacogenetics of drug metabolism. Permagon Press Inc: New York, 1992: pp. 249-259.
2. Coles B. Effects of modifying structure in electrophilic reactions with biological nucleophiles. Drug Metabolism Reviews 1984; 15: 1307-1334.
3. Hussey AJ, Hayes JD. Human Mu-class glutathione S-transferases present in liver, skeletal muscle and testicular tissue. Biochim Biophys Acta 1993; 1203; 131-141.
4. Strange RC et al. The human glutathione S-transferases: comparison of isoenzyme expression in normal and astrocytome brain. Biochim Biophys Acta 1992; 1139: 222-228.
5. Seidegård J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione S-transferase activate on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci 1988; 85: 7293-7297.
6. Van Poppel G, de Vogel N, van Bladeren PJ, Kok FJ. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme μ. Carcinogen 1992; 13: 303-305.
7. Harada S et al. Detection of GST1 gene deletion by polymerase chain reaction and its possible correlation with stomach cancer in Japanese. Hum Genet 1992; 90: 62-64.
8. Meyer JD et al. Theta, a new class of glutathione S-transferases purified from rat and human. J Biochem 1991; 274: 409-414.
9. Pemble S et al. Human glutathione S-transferase Theta (GSTT1): cDNA cloning and the characterisation of a genetic polymorphism. J Biochem 1994; 300: 271-276.
10. Webb G, Vaska V, Coggan M, Board P. Chromosomal localisation for the human theta class glutathione transferase (GSTT1). Genomics 1996; 33: 121-123.
11. Nelson HH et al. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. Carcinogen 1995; 16: 1243-1245.
12. Ploemen JHTM et al. Polymorphism in the glutathione conjugation activity of human erythrocytes towards ethylene dibromide and 1,2-epoxy-3-(p-nitrophenoxy)-propane. Biochim Biophys Acta 1995; 1243: 469-476.
13. Brockmöller J et al. Genotype and phenotype of glutathione S-transferase class μ isoenzymes μ and ψ in lung cancer patients and controls. Cancer Res 1993; 53: 1004-1011.
14. Chen J et al. Increased risk for myelodysplastic syndrome in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 1996; 347: 295-297.
15. Steventon GB, Waring RH, Williams AC. Xenobiotic metabolism in Parkinson's disease. Neurology 1989; 39: 883-887.
16. Steventon GB et al. Metabolism of low-dose paracetamol in patients with chronic neurological diseases. Neurology 1990; 20: 117-122.
17. Steventon GB et al. Xenobiotic metabolism in Alzheimer's disease. Neurology 1990; 40: 1095-1098.
18. Heafield MT et al. Plasma cysteine and sulphate levels in patients with motor neuron. Parkinson's and Alzheimer's disease. Neurosci Lett 1990; 110: 216-220.
19. Waring RH, Sturman SG, Smith MCG, Steventon GB. S-Methylation in motor neuron disease and Parkinson's disease. Lancet 1989; ii: 356-357.
20. Peters L et al. D-Penicillamine metabolism in neurodegenerative diseases an in vivo-in vitro sulphydryl methylation study. Xenobiotics 1994; 24: 1013-1020.
21. Stroombergen MCMJ, Waring RH, Bennett P, Williams AC. Determination of the GSTM1 gene deletion frequency in Parkinson's disease by allele specific PCR. Parkinsonism and related disorders 1996; 2: 151-154.
22. Smith CAD et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992; 339: 1375-1377.
23. Katoh T, Inatomi H, Nagaoka A, Sugita A. Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogen 1995; 16: 655-657.
24. Mulders TMT, Keizer HJ, Breimer DD, Mulder GJ. In vivo characterisation and modulation of the glutathione/glutathione S-transferase system in cancer patients. Drug Metabolism Reviews 1995; 27: 191-229.
25. Fryer AA et al. Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 AB, GSTM1 null locus polymorphisms at the glutathione S-transferase, GSTM1 locus. J Biochem 1993; 295: 313-315.
26. Strange RC et al. The human glutathione S-transferases: a case-control study on the incidence of the GST1 0 phenotypes in patients with adenocarcinoma. Carcinogen 1991; 12: 25-28.
27. Hirvonen A, Husgavel-Pursianen K, Antilla S, Vanio H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogen 1993; 14: 1479-1481.
28. Lin HJ et al. Ethnic distribution of the glutathione S-transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogen 1994; 15: 1077-1081.
29. Zhong S et al. Glutathione S-transferase mu locus: use of genotyping and phenotyping to assess association with lung cancer susceptibility. Carcinogen 1991; 12: 1533-1537.
30. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Molec Biol 1995; 30: 445-600.
31. Shinka T et al. Relationship between glutathione S-transferase M1 deficiency and urothelial cancer in dye water exposed aromatic amines. J Urol 1998; 159: 380-383.
32. Clapper ML et al. Chemopreventive activity of Oltipraz against N-nitrosobis (2-oxopropyl) amine (BOP)-induced ductal pancreatic carcinoma development and effects in survival of Syrian golden hamsters. Carcinogen 1995; 16: 2159-2165.
33. Huber WW et al. Chemoprotection against the formation of colon adducts from the food-borne carcinogen 2-amino-1-methyl-B-phenylimidazo [4,5-b] pyridine (Ph1P) in the rat. Mutat Res 1997; 376: 115-122.
34. Agostinelli E, Przybytkowski E, Averill-Bates DA. Glucose, glutathione and cellular responses to spermine oxidation products. Free Rad Biol Med 1996; 20: 649-656.
35. Kotake Y et al. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a Parkinsonism-inducing agent; a novel endogenous amine in mouse brain and Parkinsonism CSF. J Neurochem 1995; 65: 2633-2638.
36. Singer TP, Castagnoli N, Ramsay RR, Trevor AJ. Biochemical events in the development of Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine. J Neurochem 1987; 49: 1-8.
37. Singhal SS et al. Glutathione S-transferases of the human skin: qualitative and quantitative differences in men and women. Biochim Biophys Acta 1993; 1163: 266-272.
38. Singhal SS et al. Gender related differences in the expression and characteristics of glutathione S-transferases in human colon. Biochim Biophys Acta 1992; 1171: 19-26.
39. Krishna NSR et al. Age related and gender related trends in the expression of glutathione S-transferases in human nasal-mucosa. Annals of Otology, Rhinology and Larynology 1995; 104: 812-822.
40. Das M, Dixit R, Seth PK, Mukhtar H. Glutathione S-transferase activity in the brain: species, sex, regional and age differences. J Neurochem 1981; 36: 1439-1442.